bml 190 has been researched along with indomethacin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crews, BC; Kalgutkar, AS; Marnett, AB; Marnett, LJ; Remmel, RP | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| New, DC; Wong, YH | 1 |
| Bissonnette, CJ; Klegeris, A; McGeer, PL | 1 |
| Scutt, A; Williamson, EM | 1 |
| Chen, B; Jin, S; Li, H; Li, Y; Wan, J; Wu, P; Ye, D; Zhang, L; Zhang, X; Zhou, X | 1 |
| Cole, RB; Ma, P; Wang, G; Zhang, Q | 1 |
7 other study(ies) available for bml 190 and indomethacin
| Article | Year |
|---|---|
Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Indomethacin; Isoenzymes; Macrophages; Membrane Proteins; Mice; Prostaglandin-Endoperoxide Synthases; Sheep; Structure-Activity Relationship | 2000 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates.
Topics: Cell Line; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Synergism; Humans; Indomethacin; Inositol Phosphates; Ligands; Morpholines; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Second Messenger Systems | 2003 |
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
Topics: Astrocytes; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Cell Line; Cytokines; Dronabinol; Formazans; Gene Expression; Humans; Indoles; Indomethacin; L-Lactate Dehydrogenase; Ligands; Microglia; Monocytes; Morpholines; Nerve Degeneration; Neurotoxicity Syndromes; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; RNA, Messenger; Temporal Lobe; Tetrazolium Salts | 2003 |
Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors.
Topics: Animals; Arachidonic Acids; Benzoxazines; Bone Marrow Cells; Cannabinoid Receptor Modulators; Cannabinoids; Cells, Cultured; Colony-Forming Units Assay; Cyclohexanols; Dose-Response Relationship, Drug; Endocannabinoids; Glycerides; Indomethacin; Male; Mesenchymal Stem Cells; Morpholines; Naphthalenes; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Stem Cells | 2007 |
BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis.
Topics: Animals; Ankle Joint; Arthritis, Experimental; Cell Proliferation; Collagen Type II; Disease Models, Animal; Immunity; Immunoglobulin G; Indomethacin; Interleukin-6; Lipoxins; Male; Mice; Mice, Inbred DBA; Morpholines; Receptors, Formyl Peptide; Severity of Illness Index; Spleen; Tumor Necrosis Factor-alpha | 2008 |
In vitro metabolism of indomethacin morpholinylamide (BML-190), an inverse agonist for the peripheral cannabinoid receptor (CB(2)) in rat liver microsomes.
Topics: Animals; Chromatography, High Pressure Liquid; Indomethacin; Microsomes, Liver; Morpholines; Rats; Receptor, Cannabinoid, CB2; Spectrophotometry, Ultraviolet; Tandem Mass Spectrometry | 2010 |